Da Qing Cai
Keine laufenden Positionen mehr
Karriereverlauf von Da Qing Cai
Ehemalige bekannte Positionen von Da Qing Cai
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Direktor/Vorstandsmitglied | 20.08.2020 | 23.03.2023 |
| Independent Dir/Board Member | 20.08.2020 | 23.03.2023 | |
| BIONANO GENOMICS, INC. | Direktor/Vorstandsmitglied | 01.08.2018 | 01.08.2019 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.06.2016 | 01.03.2019 |
| BERRY GENOMICS CO.,LTD | Direktor/Vorstandsmitglied | 01.07.2017 | 01.04.2018 |
Ausbildung von Da Qing Cai
| University of Science & Technology of China | Undergraduate Degree |
| Yale University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistik
International
| China | 4 |
| Vereinigte Staaten | 4 |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BERRY GENOMICS CO.,LTD | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| BIONANO GENOMICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Börse
- Insiders
- Da Qing Cai
- Erfahrung